Cell & Gene US 2024 features 3 programmes to bring together over 400 key pharma and biotech, and academic experts from across the research & development, clinical, and manufacturing space to discuss challenges and advancements in the CGT landscape
ENGAGE with peers and selected leading solution providers in an exciting, successful networking environment
EDUCATE yourself on the latest in research and innovation in our renowned conference programme, featuring over 80 cutting edge presentations and interactive sessions
Over 400 cell culture, bioprocessing and cell line development attendees representing global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions.
Over 80 presentations and case studies focussed on the crucial issues in cell line development, bioprocessing technologies and cell culture optimisation.
Our brand-new Cell & Gene Therapy Innovation & Collaboration Track featuring pioneering presentations from emerging biotechs and spin-off companies.
Over 400 attendees from global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions pioneering cell & gene therapy manufacturing.
Over 80 presentations and case studies providing actionable insights to improve your manufacturing workflow and enable scale-up, automation and high quality.
Our brand-new Cell & Gene Therapy Innovation & Collaboration Track featuring pioneering presentations from emerging biotechs and spin-off companies.
Over 400 cell & gene therapy, stem cell development, market access and regulatory attendees representing global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions.
Over 80 presentations and case studies focussed on the key strategies delivering advanced therapies into the clinic, from developing innovative targets to establishing clear regulatory guidelines
Our brand-new Cell & Gene Therapy Innovation & Collaboration Track featuring pioneering presentations from emerging biotechs and spin-off companies.
The 2024 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below are some of the confirmed speakers for Cell & Gene US 2024
Chief Technical Officer,
Obsidian Therapeutics
Director, Analytical Development,
Cabaletta Bio
Director of Business Integration,
Bristol Myers Squibb
Vice President, Business Development & Alliances,
Prescient Therapeutics
Senior Director of Global Quality Operations,
Immatics
Chief Executive Officer & Chief Scientific Officer,
Odylia Therapeutics
Chief Scientific Officer, Rare Diseases,
Moderna Therapeutics
Vice President, Head of Translational Medicine,
Cargo Therapeutics
Vice President of Preclinical Ocular Research,
Iveric Bio, An Astellas Pharma Company
Senior Director, Translational Science & Development,
Astellas Pharma
Associate Director,
AstraZeneca
Associate Director, Cell Therapies,
Takeda
Senior Director & Head of Protein Sciences,
Invenra
Senior Director,
PTC Therapeutics
Senior Engineer III,
Biogen
Vice President, Head of Research and Development,
Versatope Therapeutics
Associate Director, Upstream Development,
Boehringer-Ingelheim
Senior Vice President, Process and Analytical Development and Clinical Manufacturing,
2seventybio
Senior Vice President, Technical Operations,
CaldiBio
Director, Supply Chain,
Carisma Therapeutics
Please enter your details into the form to register your interest and be notified once registration for this event is available.
Submit your details to be kept up to date about relevant information, events, or webinars. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
